Advisor Group Holdings, Inc. Viracta Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$1.26 - $4.38 $4,670 - $16,236	3,707 Added 432.56%	4,564 $6,000
Q2 2022 Aug 10, 2022	SELL	$1.87 - $5.0 $52 - $140	-28 Reduced 3.16%	857 $3,000
Q1 2022 May 04, 2022	SELL	$2.23 - $4.76 $9,174 - $19,582	-4,114 Reduced 82.3%	885 $190,000
Q3 2021 Nov 05, 2021	BUY	$7.84 - $12.53 $39,192 - $62,637	4,999 New	4,999 $39,000
Q2 2021 Aug 02, 2021	SELL	$7.55 - $12.95 $4,077 - $6,993	-540 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$7.58 - $18.67 $4,093 - $10,081	540 New	540 $5,000

5.63M

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $9.39M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.